Showing results (101-110 of 17,194) with videos related to
Sort By:
Pageof 1,720
Cancer Treatment Reports|February 1, 1984
Modulation of cytarabine uptake and toxicity by dipyridamoleM E King, A Naporn, B Young, et al.Somatic Cell and Molecular Genetics|March 4, 2000
Chromosomal localization and genomic structure of the human arsenite-stimulated ATPase (hASNA-I)B Kurdi-Haidar, D Heath, G Lennon, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell lineE Kimura, R E Enns, F Thiebaut, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavityM Markman, S Cleary, W E Lucas, et al.Cancer|November 15, 1985
High-dose intracavitary cisplatin with intravenous thiosulfate. Low incidence of serious neurotoxicityM Markman, S Cleary, C E Pfeifle, et al.Medical and Pediatric Oncology|January 1, 1985
Cisplatin and cytarabine administered intrapleurally as treatment of malignant pleural effusionsM Markman, S Cleary, M E King, et al.Cancer Research|February 1, 1978
Thymidine rescue of high-dose methotrexate in humansS B Howell, W D Ensminger, A Krishan, et al.Cancer Drug Delivery|January 1, 1985
The intraoperative intraperitoneal administration of cisplatin: a case reportM Markman, R Weiss, S B Howell, et al.The Journal of Biological Chemistry|August 26, 1998
Biochemical characterization of the human arsenite-stimulated ATPase (hASNA-I)B Kurdi-Haidar, D Heath, S Aebi, et al.British Journal of Cancer|February 1, 1994
Enhancement of sensitivity to platinum(II)-containing drugs by 12-O-tetradecanoyl-phorbol-13-acetate in a human ovarian carcinoma cell lineS Isonishi, D K Hom, A Eastman, et al.Pageof 1,720